- Home
- HVT vs ABEO Comparison
HVT vs ABEO Comparison
Compare HVT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | ABEO |
|---|---|---|
| Founded | 1885 | 1974 |
| Country | United States | United States |
| Employees | 2392 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 307.5M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | HVT | ABEO |
|---|---|---|
| Price | $22.47 | $5.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 77.2K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,998,000.00 |
| Revenue This Year | $8.83 | $1,024.31 |
| Revenue Next Year | $8.70 | $145.42 |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $19.32 | $4.00 |
| 52 Week High | $27.67 | $7.54 |
Technical Indicators
Market Signals| Indicator | HVT | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 46.84 |
| Support Level | $21.97 | $5.20 |
| Resistance Level | $23.54 | $5.54 |
| Average True Range (ATR) | 0.73 | 0.24 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 55.62 | 39.88 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.